skip to Main Content

2020 Statements

US FDA COVID Vaccine Authorization Important Step Toward Ending the COVID-19 Pandemic
December 11, 2020 — Today’s decision by the US Food and Drug Administration (FDA) to grant an Emergency Use Authorization (EUA) for the Pfizer-BioNTech mRNA vaccine is an important step toward bringing the COVID-19 pandemic under control in the United States.

TAG Applauds Dr. Demetre Daskalakis’ Appointment as CDC Director of the Division of HIV/AIDS Prevention: NYC’s Loss is America’s Gain
November 19, 2020 — Treatment Action Group applauds the appointment of Dr. Demetre Daskalakis to helm the U.S. Centers for Disease Control and Prevention (CDC)’s Division of HIV/AIDS Prevention (DHAP). We can think of no better public health practitioner to embody true innovation and disrupt the status quo in our national HIV prevention response.

Efficacy News from Second COVID-19 Vaccine Trial Underscores Need for Transparency and Cooperation Between Outgoing and Incoming US Administrations
November 16, 2020 — AVAC and Treatment Action Group (TAG) welcome today’s announcement that preliminary data from the efficacy trial of Moderna’s mRNA COVID-19 vaccine indicate high-level of protection against COVID-19.

Treatment Action Group Statement on Early Findings from HPTN 084
November 12, 2020 — Treatment Action Group welcomes the announcement that the phase 3 HPTN 084 trial proved that intramuscular injections of ViiV’s long acting cabotegravir (CAB-LA) every eight weeks were superior to daily oral TDF/FTC pre-exposure prophylaxis (PrEP) in preventing new HIV infections in cisgender women in sub-Saharan Africa.

Treatment Action Group and AVAC Statement on Pfizer/BioNTech COVID-19 Vaccine Efficacy Announcement
November 9, 2020 — Treatment Action Group (TAG) and AVAC welcome today’s announcement that preliminary data from the efficacy trial of Pfizer/BioNTech’s mRNA COVID-19 vaccine indicates a high level of protection against COVID-19. Our organizations urge caution, however, given the very limited information that is available only through a company press release.

TAG Welcomes the Election of Joseph R. Biden Jr. and Kamala D. Harris
November 9, 2020 — Treatment Action Group (TAG) congratulates President-elect Joe Biden and Vice President-elect Kamala Harris on their ascension to the highest offices of the United States. Their victory in both the popular and electoral vote is historic.

Finally—A New Four-Month Treatment for Drug-Susceptible TB!
October 21, 2020 — Treatment Action Group (TAG) and the Community Research Advisors Group (CRAG) welcome the news of a safe and effective regimen for shortening tuberculosis (TB) treatment to just four months.

Por fin un nuevo tratamiento de cuatro meses para la tuberculosis sensible a fármacos
October 21, 2020 — El Grupo de Acción para el Tratamiento (TAG, por sus siglas en inglés) y el Grupo de Asesores Comunitarios de Investigación (CRAG, por sus siglas en inglés) se congratulan ante la noticia de un régimen seguro y eficaz capaz de acortar el tratamiento de la tuberculosis (TB) a sólo cuatro…

Treatment Action Group Mourns the Loss of Timothy Ray Brown
September 30, 2020 — Treatment Action Group (TAG) is profoundly saddened by the news that Timothy Ray Brown—the first person in the world considered cured of HIV infection—died yesterday from a recurrence of cancer.

New York Increases Access to Hepatitis C Treatment for Medicaid Patients
September 21, 2020 — The National Viral Hepatitis Roundtable (NVHR), the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI), and the Treatment Action Group (TAG) today applauded New York State (NYS) Medicaid for removing the requirement that new patients receive prior authorization approval for hepatitis C treatment.

Archives:
Back To Top